Our analysis confirmed that MMP-2 was significantly negatively correlative with OS (HR = 1.78, p = 0.02) and progress-free interval (HR = 1.77, p = 0.04) of COAD patients (Figs. 4A, 4B). This evidence concerns the gene MMP2 and colon adenocarcinoma.